MBD2 serves as a viable target against pulmonary fibrosis by inhibiting macrophage M2 program.
Wang Y, Zhang L, Wu GR, Zhou Q, Yue H, Rao LZ, Yuan T, Mo B, Wang FX, Chen LM, Sun F, Song J, Xiong F, Zhang S, Yu Q, Yang P, Xu Y, Zhao J, Zhang H, Xiong W, Wang CY.
Wang Y, et al. Among authors: yuan t.
Sci Adv. 2021 Jan 1;7(1):eabb6075. doi: 10.1126/sciadv.abb6075. Print 2021 Jan.
Sci Adv. 2021.
PMID: 33277324
Free PMC article.